Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,567 | -21,708 | -18,367 | -10,616 | -4,804 |
| Depreciation Amortization | N/A | 36 | 36 | 27 | 14 |
| Accounts payable and accrued liabilities | -370 | -294 | 1,090 | -255 | -34 |
| Other Working Capital | -463 | 720 | 2,199 | 1,118 | 265 |
| Other Operating Activity | 1,425 | 4,569 | 1,947 | 1,758 | 529 |
| Operating Cash Flow | $-1,975 | $-16,677 | $-13,095 | $-7,968 | $-4,030 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12 | 62 | 61 | 42 | 27 |
| Other Financing Activity | -46 | -106 | -66 | -44 | 0 |
| Financing Cash Flow | $-34 | $-44 | $-5 | $-2 | $27 |
| Beginning Cash Position | 42,044 | 58,765 | 58,765 | 58,765 | 58,765 |
| End Cash Position | 40,035 | 42,044 | 45,665 | 50,795 | 54,762 |
| Net Cash Flow | $-2,009 | $-16,721 | $-13,100 | $-7,970 | $-4,003 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,975 | -16,677 | -13,095 | -7,968 | -4,030 |
| Free Cash Flow | -1,975 | -16,677 | -13,095 | -7,968 | -4,030 |